HHS sets the risk adjustment methodology that it uses in states that elect not to operate the program in advance of each benefit year through a notice-and-comment rulemaking process with the intention ...
The U.S. Food and Drug Administration recently issued a draft guidance titled, “Benefit-Risk Assessment for New Drug and Biological Products,” which aims to provide a clearer understanding how a ...
CEO of Schwenk AG & Crisis Control Solutions LLC, a leading expert in risk and crisis management for the automotive industry. In the intricate tapestry of the modern business landscape, every thread ...